Neoantigens, which are molecules found on tumor cells that incorporate mutations, help our immune system fight cancers and could be the most promising components of future cancer vaccines—if only scientists knew with a high degree of certainty which neoantigens work. A collaboration of scientists…

In a new study in NPJ Genomic Medicine, researchers at the University of Notre Dame have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.

Four PhD students at the University of Notre Dame have joined the Eck Institute for Global Health as graduate research fellows. The Institute will support the students as they pursue topics…